E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
Globe Newswire•06/08/2026•08:15 ET
0
Whiz Insights
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as exclusive financial advisor in connection with a $5.5 million financing for Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK).
The financing was led by participating institutional investors and consisted of a $2.0 million equity financing, priced at $0.75 per unit, together with a $3.5 million follow-on investment in the form of convertible debt.
Get started
Create a free account to read the full story.